News

UK Donors’ Plasma Safety

Sep 01, 2020
A Supplementary Memorandum prepared for the Medicines and Healthcare products Regulatory Agency (MHRA)and the Commission on Human Medicines (CHM)as part of the UK plasma policy review 2020. link